Consumer protection: unfair trade practices; insulin drug pricing report; require by the department of attorney general. Amends 1976 PA 331 (MCL 445.901 - 445.922) by adding sec. 9b.

1. **ONE-SENTENCE SUMMARY**: This bill requires the Michigan Department of Attorney General to report on unfair trade practices related to insulin drug pricing. 2. **KEY REQUIREMENTS**: - Stay informed about insulin pricing practices and any updates from the Department of Attorney General. - Be prepared to provide information if requested regarding pricing and trade practices related to insulin. 3. **DEADLINES**: - The bill is currently in the introduction stage; effective dates and compliance deadlines will be established once passed. 4. **PENALTIES**: - Non-compliance could lead to enforcement actions by the Attorney General, which may include fines or other penalties. 5. **SMB IMPACT**: Small businesses involved in the sale or distribution of insulin may need to adjust their pricing strategies and ensure transparency in their practices to comply with potential future regulations. Staying compliant will help avoid penalties and maintain consumer trust.